CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- 4 Planned sale See Remarks sold 1,922 shares at $10.02 ($19,258)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP, Finance and Controller sold 390 shares at $8.61 ($3,358)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale VP, Finance and Controller sold 389 shares at $8.68 ($3,377)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Legal Officer sold 1,635 shares at $10.90 ($17,822)
- 4 Option exercise Director acquired 9,333 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Legal Officer sold 1,635 shares at $10.59 ($17,315)
- 4 Planned sale Chief Legal Officer sold 2,678 shares at $12.00 ($32,136)
- 4 Planned sale Chief Legal Officer sold 1,635 shares at $10.17 ($16,628)
- 4 Planned sale Chief Legal Officer sold 2,408 shares at $10.00 ($24,080)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Legal Officer sold 2,407 shares at $8.00 ($19,256)
- 4 Derivatives Options or other derivatives
Page 2 of 9 · 170 filings